Matthias G Wacker Selected Research

Matthias G Wacker Research Topics

4	Neoplasms (Cancer) 01/2021 - 08/2015
2	Inflammation (Inflammations) 03/2022 - 01/2022
2	Multiple Sclerosis 03/2021 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2018
2	Chronic Disease (Chronic Diseases) 01/2019 - 01/2018
1	Pain (Aches) 03/2022
1	Osteoarthritis 03/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2022
1	Infections 01/2022
1	Necrosis 01/2022
1	Skin Diseases (Skin Disease) 01/2022
1	Hidradenitis Suppurativa 01/2022
1	Stroke (Strokes) 10/2019
1	Hepatocellular Carcinoma (Hepatoma) 09/2019
1	Deglutition Disorders (Dysphagia) 01/2019
1	Squamous Cell Carcinoma of Head and Neck 01/2019
1	Wounds and Injuries (Trauma) 01/2018

6	Pharmaceutical PreparationsIBA 01/2022 - 01/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2022
2	tarenflurbilIBA 03/2021 - 01/2019
2	temoporfinIBA 01/2019 - 08/2015
1	BerberineIBA 03/2022
1	GelsIBA 03/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Biological ProductsIBA 01/2022
1	Clindamycin (Cleocin)FDA LinkGeneric 01/2022
1	InterleukinsIBA 01/2022
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	CytokinesIBA 01/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Nerve Growth Factor (NGF)IBA 10/2019
1	NeuropeptidesIBA 10/2019
1	AlbuminsIBA 10/2019
1	Sorafenib (BAY 43-9006)FDA Link 09/2019
1	Propylene Glycol (1,2 Propanediol)FDA LinkGeneric 01/2019
1	Ethanol (Ethyl Alcohol)IBA 01/2019
1	Radiation-Sensitizing AgentsIBA 08/2015

6	Therapeutics 01/2022 - 01/2018
2	Precision Medicine 10/2019 - 09/2019
2	Photochemotherapy (Photodynamic Therapy) 01/2019 - 08/2015
1	Drug Therapy (Chemotherapy) 01/2019
1	Radiotherapy 08/2015